ESR1 and breast cancer: In vitro, RAP-RSV-LIP liposomes were internalized by estrogen receptor-positive MCF-7 breast cancer cells, achieving 34.2% cellular uptake and exhibiting enhanced cytotoxicity compared to free drugs.